AISAP Cardio vs Cardiac Guidance

Direct competitors — feature-level head-to-head below. Comparability 80/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Aisap
VS
by Caption Health

AI Verdict

Both AISAP Cardio and Cardiac Guidance are FDA-cleared AI tools for point-of-care cardiac ultrasound, offering automated measurements like Left Ventricle Ejection Fraction. AISAP Cardio focuses on comprehensive diagnostic assessments, interpretations, and reporting for various cardiac conditions. In contrast, Cardiac Guidance uniquely emphasizes real-time AI guidance for image acquisition, enabling non-expert users to capture diagnostic-quality cardiac ultrasound images.

Choose AISAP Cardio if…

Choose AISAP Cardio if your primary need is a comprehensive, AI-powered diagnostic assessment platform for structural heart disease and heart failure, providing detailed measurements and automated reports. This tool is ideal for clinicians who require advanced AI interpretation of various cardiac pathologies and seamless integration with existing EHR/EMR and PACS systems for a complete diagnostic workflow.

View AISAP Cardio →

Choose Cardiac Guidance if…

Choose Cardiac Guidance if your goal is to empower a broader range of healthcare professionals, including those without extensive ultrasound experience, to acquire diagnostic-quality cardiac ultrasound images at the point of care. This tool excels in providing real-time, turn-by-turn AI guidance for probe movement and automated quality assessment, ensuring consistent and high-quality image acquisition for critical cardiac assessments.

View Cardiac Guidance →

When choosing between AISAP Cardio and Caption Health’s Cardiac Guidance, physicians should consider their primary need: automated interpretation or guided acquisition. AISAP Cardio excels at providing rapid, comprehensive cardiac diagnostic assessments and measurements, automatically generating analyses and reports for early detection of structural heart disease and heart failure. It offers a broad range of measurements, including valvular pathologies and ventricular dimensions, making it suitable for users who need in-depth, AI-powered interpretation of existing ultrasound images or for those who are already proficient in image acquisition.

The key practical difference lies in their core functionality. AISAP Cardio focuses on the interpretation and reporting of cardiac ultrasound data, acting as an AI-powered diagnostic assistant. In contrast, Cardiac Guidance is designed to empower healthcare professionals, including non-expert ultrasound users, to acquire diagnostic-quality cardiac ultrasound images through real-time AI guidance and on-screen probe movement instructions. Physicians who prioritize ease of image acquisition and require assistance in obtaining standard echocardiographic views should lean towards Cardiac Guidance. Conversely, those with established ultrasound acquisition skills who need advanced, automated interpretation and comprehensive reporting should opt for AISAP Cardio.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AISAP Cardio Cardiac Guidance
Pricing Not publicly available Contact vendor
Deployment Cloud-based SaaS platform Software accessory integrated with compatible general purpose diagnostic ultrasound systems (e.g., GE HealthCare Venue Family, Vscan Air SL, Terason uSmart 3200t Plus).
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiac Guidance

Tool B (Cardiac Guidance) excels in usability by providing real-time AI guidance, including turn-by-turn on-screen probe movement instructions and an automated 'Quality Meter' to assist non-expert ultrasound users in acquiring diagnostic-quality images. While Tool A (AISAP Cardio) also aims to be user-friendly for less experienced operators by providing real-time feedback on image quality and automating interpretation, Tool B's explicit guidance for the acquisition process itself is a more direct enhancement to usability for novice users.

Clinical Value

AISAP Cardio

Both tools are FDA-cleared and offer significant clinical value. However, Tool A (AISAP Cardio) provides a more comprehensive cardiac diagnostic assessment, including detailed measurements of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), Left Ventricle Ejection Fraction (LVEF), and various ventricular and atrial dimensions. This broad range of diagnostic outputs offers more immediate and extensive clinical insights compared to Tool B's focus on image acquisition and automated EF calculation.

Pricing & Value

Cardiac Guidance

While neither tool publicly discloses specific pricing, Tool B (Cardiac Guidance) offers a clearer value proposition by having secured CMS New Technology Add-on Payment (NTAP) status. This enables hospitals to receive reimbursement for its use, directly addressing financial barriers and enhancing its overall value for eligible institutions. Tool A mentions a user-based subscription model but lacks similar public information on reimbursement or cost recovery.

Enterprise Readiness

AISAP Cardio

Tool A (AISAP Cardio) demonstrates stronger enterprise readiness with its explicit mention of being a cloud-based SaaS platform, vendor-agnostic, scalable, and offering integration with existing clinical workflows, EHR/EMR, and PACS. It is also confirmed to be HIPAA-compliant and ISO-certified. While Tool B is integrated with compatible ultrasound systems and is part of GE HealthCare, Tool A's broader compatibility and integration capabilities suggest greater flexibility for diverse enterprise environments.

Innovation

Cardiac Guidance

Both tools leverage AI innovatively in cardiac ultrasound. However, Tool B (Cardiac Guidance) stands out by providing real-time AI guidance for *image acquisition*, including turn-by-turn probe movement instructions, specifically designed to empower non-expert users to obtain diagnostic-quality images. This approach to democratizing access to cardiac ultrasound by simplifying the acquisition process itself represents a more disruptive innovation.

Support & Docs

Cardiac Guidance

Tool B (Cardiac Guidance) explicitly states that an 'Operator's Manual' is available for instructions, warnings, and other support information, and that this document can be accessed directly from the software interface. This indicates readily available and integrated documentation. Tool A does not provide specific details regarding its support or documentation in the provided information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AISAP Cardio Cardiac Guidance
Product Name AISAP Cardio Cardiac Guidance
Company Aisap Caption Health
Primary Function FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. FDA-cleared AI tool that empowers healthcare professionals to acquire and interpret diagnostic-quality cardiac ultrasound images at the point of care, democratizing access to critical cardiac assessments.
Core AI Focus AI-powered interpretation for early cardiac disease detection; Automated generation of analyses, interpretations, and reports. Real-time AI guidance for cardiac ultrasound image acquisition; Turn-by-turn on-screen probe movement instructions; Automated quality assessment with a 'Quality Meter'; Auto-capture of diagnostic-quality images and video clips.
LVEF Calculation Measurement of Left Ventricle Ejection Fraction (LVEF) Automated left ventricular ejection fraction (EF) calculation (Caption Interpretation)

Videos

Demos, reviews, and walkthroughs featuring AISAP Cardio and Cardiac Guidance.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AISAP Cardio primarily focuses on providing rapid, comprehensive cardiac diagnostic assessments and measurements, including automated interpretations and reports. Cardiac Guidance, conversely, emphasizes real-time AI guidance for image acquisition, helping users capture diagnostic-quality cardiac ultrasound images, in addition to automated EF calculation.
Cardiac Guidance is explicitly designed for use by non-expert ultrasound users, offering real-time AI guidance with turn-by-turn probe movement instructions and automated quality assessment. AISAP Cardio focuses on comprehensive assessments and measurements, implying a user who is already performing point-of-care ultrasound.
AISAP Cardio offers assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), LVEF measurement, and measurements of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. Cardiac Guidance provides automated left ventricular ejection fraction (EF) calculation and supports the acquisition of 10 standard echocardiographic views.
AISAP Cardio is designed for integration with existing clinical workflows, EHR/EMR, and PACS as a vendor-agnostic solution. Cardiac Guidance integrates as a software accessory directly with compatible general purpose diagnostic ultrasound systems.
AISAP Cardio provides AI-powered interpretation for early cardiac disease detection, automated generation of analyses, interpretations, and reports. Cardiac Guidance offers real-time AI guidance for cardiac ultrasound image acquisition, including probe movement instructions and automated quality assessment, alongside automated EF calculation.
AI Tool Finder
AI-powered search. Results may not be comprehensive.